Sweden and Denmark – this is how they choose their strategies

Scandinavia’s two major powers in pharmaceutical research have developed strategies for growth in life science, and both countries aim to become world leaders.

Anna Törner: You won’t find this many Concorde projects anywhere else

"Suddenly Concorde projects seem reasonable in life science because it´s about life and death", writes Anna Törner in a column.

Marie Gårdmark: Big data evidence generation drives change in the EU regulatory system

Rapid developments in technology have led to the possibility for the generation and analysis of vast volumes of data. Will the availability of big data lead to fundamental changes to the regulatory system? In a column Marie Gårdmark, CEO and Senior Consultant at RegSmart Life Science, develops her views on this subject.

Column: Why there cannot be a complete cure for cancer – but there is certainly another way!

"Is there a new way we need to be thinking about how to prevent cancer?" Lucy Robertshaw reflects upon which is the smartest way to beat cancer.

Column: Repurposing as a golden ticket to approval

"Hopefully, in the end, patients will be winners by receiving on-label treatments for which benefit-risk has been properly assessed." In a column Marie Gårdmark, CEO at RegSmart Life Science, reflects on drug repurposing.

Lucy Robertshaw: There is a bio revolution happening right now

Lucy Robertshaw is both proud and excited to be taking the baton of moderating this year’s Pharma Outsourcing event.

Delivering drugs with small devices

There are many challenges to overcome when delivering a drug orally. Getting the drug to survive the low pH of the ventricle and being released at the correct site in the gastrontestinal tract are two of them.

Marie Gårdmark: Do EMA and FDA talk to each other?

Of course they do! The collaboration started already in 2003, writes Marie Gårdmark in a column.

Rekordmånga läser Life Science Sweden

Intresset för tidningen har ökat kraftigt. Under våren har antalet besökare tredubblats.

Swedish Healthtech Company 1928 Pushing Forward

The full service analytics platform is expanding the business.

Helena Strigård: The rise of the community

Sweden Bio´s CEO is looking back at the last decade of development in the industry. Something has shifted in the interdependence between small and larger companies.

Pilots want to live too

Krönika: Can regulators keep up with innovation?

New technology has increased the understanding of disease mechanisms and enabled approval of products targeting small but specific patient populations; sometimes referred to as precision medicine. Gene- and cell therapies have reached the market, exemplified by CAR-T cells, and the research pipeline is promising. In addition, the medical device field is constantly growing creating new solutions to address patient needs.

Astra satsar en miljard dollar på minskade utsläpp

Astrazeneca satsar en 1 miljard dollar på att eliminera koldioxidutsläppen från den globala verksamheten till 2025 och säkerställa att hela värdekedjan är koldioxidnegativ till 2030.

Before you choose a CRO

– We are a small company and it is very important for us to maintain our core competence within development of novel nanomaterials, Tove Sivik Sonne, Head of Development at Spago Nanomedical says.

Pharma-on-Demand

Make or buy? That is the question that the pharma world has been asking more and more in the last couple of decades. Pernille Hemmingsen is moderator at Pharma Outsourcing Dec 10th i Stockholm. This is her thoughts about outsourcing.

Så påverkas du av nya regelverket

I maj 2020 slutar nuvarande regelverk för medicinteknik att gälla och den nya förordningen träder i full kraft. ”Det kommer bli knepigt”, konstaterar Swedish Medtechs Petrus Laestadius under Fokus Hjälpmedel i Stockholm.

Tio år av medicinsk triumf

Immunterapi mot cancer, malariamedicin och utvecklandet av provrörsbefruktning - Nobelpriset i fysiologi eller medicin lämnar få oberörda. Här har vi sammanfattat de senaste tio årens makalösa upptäckter.

Vill maxa nyttan av forskningsinfrastrukturen

För att dra maximal nytta av investeringar i forskningsinfrastruktur ska Vetenskapsrådet och Vinnova samordna arbetet kring jättesatsningarna ESS och MAX IV.

Får nyckelposition i SKL

Daniel Forslund (L) har valts till ordförande för Beredningen för digitalisering i Sveriges Kommuner och Landsting, SKL.

Mäktigast i medtechvärlden 2019

Innovativ medicinteknik gör ingen nytta om den inte används i vården. Politik och organisationer kan göra vettig medicinteknik tillgänglig för alla patienter som behöver - eller inte. Vård bedrivs av patienter själva och av personal, men det är delvis andra som styr folkhälsoarbetet, prevention och den vård som faktiskt når människor. Här är de 100 som har mest makt och ansvar i medtech-världen 2019.

Brexit creeping closer – or?

In this column, lawyer Pernilla Norman, tries to sort out the different Brexit options.

Meet the governmental life science office

More clinical trials, promotion for digitisation and interoperability together with increased use of data generated by both healthcare and individuals. The duties of the Life Sciences office are plentiful.

Astra gör sig av med rättigheter till läkemedel

Säljer rättigheterna till rekordpreparatet Losecs efterträdare.